ADAR1 Capital Management, LLC

Position in OABI — OmniAb, Inc.

CIK 1940272 AUSTIN, TX

Position in OABI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,330,633

+$1,223,485 QoQ

Shares Held

947,412

+34.3% QoQ

Ownership

0.652%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#14

of 141 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. OABI ranks #105 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,804,703	$240,494,721
2	PTGX	Protagonist Therapeutics, Inc	960,863	$117,782,586
3	ROIV	Roivant Sciences Ltd.	3,157,008	$111,726,513
4	IMVT	Immunovant, Inc.	2,330,716	$89,802,487
5	ZLAB	Zai Lab Ltd	3,369,034	$64,011,646
6	AGIO	Agios Pharmaceuticals, Inc.	1,288,053	$47,799,646
7	CRNX	Crinetics Pharmaceuticals, Inc.	1,222,080	$45,730,233
8	CYTK	Cytokinetics Inc	457,907	$39,009,097

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,330,633	947,412	+34.3%	Shares	Sole	2026-08-14
2026-03-31	$1,107,148	705,190	+0.4%	Shares	Sole	2026-05-18
2025-12-31	$1,299,051	702,190	-35.6%	Shares	Sole	2026-02-18
2025-09-30	$1,745,004	1,090,628	+234.4%	Shares	Sole	2025-11-14
2025-06-30	$567,427	326,108	+158.6%	Shares	Sole	2025-08-14
2025-03-31	$302,659	126,108	-54.7%	Shares	Sole	2025-05-15
2024-12-31	$984,502	278,108	-79.2%	Shares	Sole	2025-02-13
2024-09-30	$5,656,787	1,337,302	+87.7%	Shares	Sole	2024-11-14
2024-06-30	$2,672,100	712,560	+57.8%	Shares	Sole	2024-08-13
2024-03-31	$2,447,048	451,485	-5.6%	Shares	Sole	2024-05-15
2023-12-31	$2,950,315	478,171	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.